Supernus, Inc. (SUPN)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS45579U1097
29.08 USD
-0.43% today Updated 13 Nov 2026 16:58
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Supernus, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:58. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 1.03
Last results
1.32 vs 1.13 estimated
29 Oct 2026 · Beat +17.2%
Beat the estimate
11 of 12
1 missed · 0 in line · 10 beats in a row
Average surprise
+39.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 1.03 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 1.13 | 1.32 | +17.2% | Beat |
| 03 Aug 2026 06:00 | 0.92 | 1.15 | +24.8% | Beat |
| 30 Apr 2026 07:00 | 0.66 | 0.96 | +45.5% | Beat |
| 26 Feb 2026 07:00 | 0.67 | 0.82 | +21.7% | Beat |
| 30 Oct 2025 07:00 | 0.41 | 0.72 | +74.9% | Beat |
| 31 Jul 2025 07:00 | 0.25 | 0.51 | +104.0% | Beat |
| 24 Apr 2025 02:00 | 0.23 | 0.41 | +75.7% | Beat |
| 20 Feb 2025 02:00 | 0.26 | 0.32 | +22.7% | Beat |
| 24 Oct 2024 02:00 | 0.41 | 0.54 | +32.8% | Beat |
| 25 Jul 2024 06:00 | 0.40 | 0.44 | +9.1% | Beat |
| 25 Apr 2024 02:00 | 0.42 | 0.37 | -10.8% | Miss |
| 22 Feb 2024 02:00 | 0.28 | 0.43 | +53.6% | Beat |
| 09 Nov 2023 02:00 | 0.30 | 0.34 | +13.3% | Beat |
| 27 Jul 2023 02:00 | 0.22 | 0.39 | +77.3% | Beat |
| 09 May 2023 16:00 | 0.31 | 0.68 | +120.6% | Beat |
| 28 Feb 2023 16:00 | 0.68 | 0.68 | +0.4% | In line |
| 08 Nov 2022 17:00 | 0.46 | 0.52 | +14.5% | Beat |
| 04 Aug 2022 16:00 | 0.29 | 0.14 | -51.7% | Miss |
| 09 May 2022 16:00 | 0.45 | 0.43 | -4.4% | Miss |
| 13 Apr 2022 16:00 | 0.24 | 0.04 | -83.1% | Miss |
| 03 Nov 2021 16:00 | 0.23 | 0.40 | +72.0% | Beat |
| 04 Aug 2021 16:00 | 0.20 | 0.43 | +117.7% | Beat |
| 05 May 2021 16:00 | 0.24 | 0.11 | -54.6% | Miss |
| 25 Feb 2021 16:00 | 0.49 | 0.57 | +16.3% | Beat |
| 03 Nov 2020 16:00 | 0.27 | 0.74 | +170.7% | Beat |
| 17 Aug 2020 16:00 | 0.42 | 0.65 | +54.8% | Beat |
| 05 May 2020 19:00 | 0.26 | 0.40 | +53.9% | Beat |
| 25 Feb 2020 16:00 | 0.59 | 0.62 | +5.8% | Beat |
| 05 Nov 2019 16:00 | 0.59 | 0.54 | -8.5% | Miss |
| 06 Aug 2019 16:00 | 0.60 | 0.61 | +1.2% | Beat |
| 07 May 2019 17:00 | 0.47 | 0.34 | -26.9% | Miss |
| 26 Feb 2019 16:00 | 0.29 | 0.48 | +67.2% | Beat |
| 06 Nov 2018 16:00 | 0.42 | 0.52 | +22.9% | Beat |
| 07 Aug 2018 16:00 | 0.45 | 0.57 | +26.7% | Beat |
| 08 May 2018 16:00 | 0.32 | 0.49 | +51.9% | Beat |
| 27 Feb 2018 16:00 | 0.28 | 0.26 | -7.6% | Miss |
| 06 Nov 2017 17:00 | 0.28 | 0.30 | +6.7% | Beat |
| 02 Aug 2017 16:00 | 0.24 | 0.33 | +36.5% | Beat |
| 09 May 2017 16:00 | 0.25 | 0.19 | -24.0% | Miss |
| 28 Feb 2017 19:00 | 0.35 | 0.35 | 0.0% | In line |
| 20 Jan 2017 17:00 | 0.27 | 0.50 | +85.2% | Beat |
| 02 Aug 2016 16:00 | 0.34 | 0.55 | +64.2% | Beat |
| 04 May 2016 06:00 | 0.09 | 0.10 | +13.8% | Beat |
| 18 Feb 2016 02:00 | 0.20 | 0.35 | +75.0% | Beat |
| 04 Nov 2015 06:00 | 0.02 | 0.08 | +274.1% | Beat |
| 04 Aug 2015 20:00 | 0.03 | 0.04 | +28.6% | Beat |
| 05 May 2015 17:00 | 0.02 | 0.06 | +224.7% | Beat |
| 10 Mar 2015 17:00 | -0.02 | 0.08 | +500.0% | Beat |
| 11 Nov 2014 16:00 | 0.32 | -0.05 | -114.9% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 719M | +8.6% | -38.6M | -5.4% | -0.68 | -151.5% | 46M |
| 2024 | 661.8M | +8.9% | 73.9M | 11.2% | 1.32 | +6,500.0% | 171.2M |
| 2023 | 607.5M | -8.9% | 1.3M | 0.2% | 0.02 | -98.1% | 110.5M |
| 2022 | 667.2M | — | 60.7M | 9.1% | 1.04 | — | 116.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 35.43 | 37.02 | 25.92 | 29.08 | -17.80% | 47,114,854 | 8.1300 |
| Oct 2026 | 35.85 | 37.00 | 32.31 | 35.37 | -1.34% | 60,350,700 | |
| Sep 2026 | 35.00 | 37.05 | 33.74 | 35.85 | +2.63% | 41,823,300 | |
| Aug 2026 | 40.31 | 41.18 | 34.33 | 34.93 | -12.70% | 54,747,100 | |
| Jul 2026 | 41.28 | 41.88 | 38.56 | 40.01 | -2.49% | 33,618,600 | |
| Jun 2026 | 35.66 | 42.81 | 32.41 | 41.03 | +13.91% | 42,002,100 | |
| May 2026 | 37.39 | 41.00 | 35.51 | 36.02 | -2.07% | 43,907,100 | |
| Apr 2026 | 30.81 | 39.33 | 29.65 | 36.78 | +20.67% | 36,719,500 | |
| Mar 2026 | 32.30 | 35.34 | 27.68 | 30.48 | -6.85% | 81,359,800 | |
| Feb 2026 | 35.43 | 36.03 | 31.55 | 32.72 | -7.52% | 33,636,300 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London (opens in a new tab) 10 Nov 2026 13:30
- Supernus (SUPN) Stock Still Looks Undervalued As Its 127% 5 Year Run Continues (opens in a new tab) Simply Wall St. · 10 Nov 2026 06:11
- Supernus undervalued after Indivior merger, says Bank of America (opens in a new tab) Proactive · 09 Nov 2026 18:45
- This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday (opens in a new tab) Benzinga · 09 Nov 2026 12:30
- B of A Securities Initiates Coverage On Supernus with Buy Rating, Announces Price Target of $47 (opens in a new tab) Benzinga · 09 Nov 2026 08:22
- Supernus Pharmaceuticals (SUPN) After Its Indivior Merger Looks Undervalued (opens in a new tab) Simply Wall St. · 04 Nov 2026 14:18
- Piper Sandler Reinstates Overweight on Supernus, Announces $47 Price Target (opens in a new tab) Benzinga · 04 Nov 2026 13:25
- Cantor Fitzgerald Maintains Overweight on Supernus, Raises Price Target to $87 (opens in a new tab) Benzinga · 04 Nov 2026 06:06
- Supernus Pharmaceuticals (SUPN) Stock May Be Undervalued After ONAPGO Exclusivity (opens in a new tab) Simply Wall St. · 03 Nov 2026 22:22
- What Changes For Supernus Pharmaceuticals (SUPN) After Its Nasdaq Delisting And Merger? (opens in a new tab) Simply Wall St. · 03 Nov 2026 19:15
- Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader (opens in a new tab) 02 Nov 2026 14:18
- SUPN Q3 deep dive: robust portfolio growth and integration priorities amid Indivior merger (opens in a new tab) StockStory · 01 Nov 2026 01:55
- Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Turnaround Narrative (opens in a new tab) Simply Wall St. · 30 Oct 2026 22:20
- Supernus (SUPN) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 30 Oct 2026 15:44
- Supernus Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 29.20 USD
- Market cap
- 6.1B
- Last dividend
- 8.1300 USD · 03 Nov 2026
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 03 Nov 2026 | 8.1300 USD |
Why this score
Similar shares
Follow SUPN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.